English News

Denmark becomes the first European country to completely ban AstraZeneca’s Kovid-19 vaccine

Oxford-AstraZeneca vaccine (file photograph)

Denmark determined to not resume utilizing the Oxford-AstraZeneca vaccine.

Copenhagen. Denmark on Wednesday determined to not resume utilizing the Oxford-AstraZeneca vaccine. Denmark postponed using this vaccine final month amid experiences of blood clots in some folks. Soren Brostrom, director of the Danish Health Authority, instructed reporters, ‘Denmark’s vaccination marketing campaign will go forward with out the AstraZeneca vaccine.’

Brostrom said that ‘there’s a potential cross-reaction between vaccines and low platelet counts. We additionally know that there’s a short-term relationship. It happens one week to 10 days after vaccination with AstraZeneca. ‘ Brostrom said that ‘the choice is related. Most of the inhabitants in Denmark has been vaccinated and is underneath epidemic management. ‘

He mentioned that ‘I can perceive nicely that different nations are utilizing vaccines’. The Danish Health Authority additionally mentioned that ‘if the scenario adjustments, then the vaccine could be reintroduced later’.

The European Union will negotiate with Pfizer to increase settlement for Kovid vaccinesEarlier, the top of the European Union Commission, Ursula von der Leyen, on Wednesday introduced plans to increase an settlement with the Pfizer firm for Kovid-19 vaccines. The time period of this settlement is to be prolonged until 2023. Von der Leyen mentioned that the European Union (EU) would begin negotiations to purchase 1.8 billion doses of Pfizer-BioNotech by 2023. The Pfizer-BioNotech firm has been the mainstay of Europe’s vaccination marketing campaign.

Von der Leyen expressed full confidence within the method used for the Pfizer-BioNotech vaccine. This method is totally different from the method used within the Oxford-AstraZeneca vaccine. He mentioned that we have to concentrate on these methods which have proved their impression.

Pfizer-BioNotech plans to supply a further 5 million doses to the European Union within the second quarter of this yr. These doses can be totally different from the 200 million doses already accredited for the EU. The announcement is about to be welcomed by 27 EU member states amid fears of potential blood clots from the Oxford-AstraZeneca vaccine and delays in vaccine provides. (With language enter)



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
DMCA.com Protection Status